FDA Inspection 1245831 — American Red Cross Biomedical Services Northern New England Region
The FDA completed an inspection of American Red Cross Biomedical Services Northern New England Region on July 31, 2024 in Burlington, VT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 31, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Burlington, VT (United States)